Risk of death from any cause about 40% higher for women whose treatment went beyond 37 weeks. »
08/23/22

Elevated fibrinogen levels after neoadjuvant therapy associated with significant disadvantage for OS. »
11/19/22

Sorafenib inhibited proliferation of all cells, except ECC line CCC5. »
11/19/22

Patients who received nilotinib or dasatinib switched therapies less frequently than patients treated with imatinib. »
11/19/22

CRT following ESD seems promising nonsurgical strategy. »
11/19/22

Exercise induces metabolic reprogramming of internal organs that increases nutrient demand and protects against metastatic colonization. »
01/25/22

RNA-based molecular signature identified that discriminated between individuals who had disease progression in ≤6 months versus >6 months. »
08/19/22

Higher levels of 11-hydroxytestosterone and 11-ketotestosterone observed in men with PSA >20. »
11/15/22

Chromosome 3p24, which encompasses RBMS3, frequently lost in non-small cell lung cancer. »
09/22/21

DpR to induction therapy prognostic but not predictive for efficacy. »
08/09/22